Cleveland Clinic Abu Dhabi has become the first hospital in the region to introduce new minimally invasive treatment for glaucoma and is planning to treat cancer patients this year. Its aim is to eliminate the need for patients to travel abroad for the necessary treatment and care.
A new technology that has the ability to immediately lower eye pressure and effectively treat the progressive damage that glaucoma can cause to the optic nerve, while also reducing or eliminating the reliance on medication in most patients, is now available in the UAE at Cleveland Clinic Abu Dhabi.
The new minimally invasive PreserFlo MicroShunt procedure involves inserting a small biocompatible stent into the drainage system of the eye in order to shunt intraocular fluid and lower pressure inside the eye. This procedure enables patients to quickly recover at home.
Cleveland Clinic Abu Dhabi has also begun the construction of its new cancer centre. When it opens, the centre will offer oncological screening, diagnostics and treatments, ensuring that cancer patients have access to comprehensive care in the UAE and the region. The new centre is scheduled to begin receiving patients later this year.
Cancer is the third most common cause of death in the UAE and the primary reason patients travel overseas. The centre will have 24 exam rooms, 24 infusion rooms, two procedure rooms, and an area devoted to women’s oncology services.
©2024 All rights reserved LaingBuisson 
